Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Moss

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLsR Khanna, S R Burrows, S A Thomson, et al.
Virology|December 20, 1995
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillanceR Khanna, S R Burrows, P M Steigerwald-Mullen, et al.
Oncogenesis|April 5, 2013
Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expressionR Carter, D Mullassery, V See, et al.
The Journal of Biological Chemistry|July 4, 2001
Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognitionJ Tellam, M Sherritt, S Thomson, et al.
Journal of Virology|October 29, 1997
Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic driftR Khanna, R W Slade, L Poulsen, et al.
European Journal of Immunology|July 1, 1997
Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivityS R Burrows, S L Silins, R Khanna, et al.
Science (New York, N.Y.)|October 3, 1980
Atmospheric carbon dioxide, the southern oscillation, and the weak 1975 el ninoR B Bacastow, J A Adams, C D Keeling, et al.
Pigment Cell Research|January 1, 1989
Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cellsM McEwan, P G Parsons, D J Moss, et al.
International Journal of Cancer|September 15, 1990
Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cellsI S Misko, C Schmidt, N Martin, et al.
The Journal of Clinical Investigation|October 28, 1998
A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infectionS L Silins, S M Cross, K G Krauer, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLsR Khanna, S R Burrows, S A Thomson, et al.
Virology|December 20, 1995
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillanceR Khanna, S R Burrows, P M Steigerwald-Mullen, et al.
Oncogenesis|April 5, 2013
Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expressionR Carter, D Mullassery, V See, et al.
The Journal of Biological Chemistry|July 4, 2001
Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognitionJ Tellam, M Sherritt, S Thomson, et al.
Journal of Virology|October 29, 1997
Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic driftR Khanna, R W Slade, L Poulsen, et al.
European Journal of Immunology|July 1, 1997
Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivityS R Burrows, S L Silins, R Khanna, et al.
Science (New York, N.Y.)|October 3, 1980
Atmospheric carbon dioxide, the southern oscillation, and the weak 1975 el ninoR B Bacastow, J A Adams, C D Keeling, et al.
Pigment Cell Research|January 1, 1989
Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cellsM McEwan, P G Parsons, D J Moss, et al.
International Journal of Cancer|September 15, 1990
Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cellsI S Misko, C Schmidt, N Martin, et al.
The Journal of Clinical Investigation|October 28, 1998
A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infectionS L Silins, S M Cross, K G Krauer, et al.
Pageof 18